PROVIDER PROFILE · NPI 1629041199

Mark BrowningMD

PRESCRIBING · PART D · 2024
Total Rx claims
109
Beneficiaries
Total drug cost
$22K
Distinct drugs
6
Brand share
33.0%
Top prescribed drugs
Apixaban36 claims
Acyclovir17 claims
Anastrozole17 claims
Hydroxyurea16 claims
Letrozole12 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.